img

Global High Affinity Nerve Growth Factor Receptor Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global High Affinity Nerve Growth Factor Receptor Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global High Affinity Nerve Growth Factor Receptor market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, ASP-7962 accounting for % of the High Affinity Nerve Growth Factor Receptor global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Bile Duct Cancer segment is altered to an % CAGR throughout this forecast period.
The global key companies of High Affinity Nerve Growth Factor Receptor include Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, Daiichi Sankyo Co Ltd, Dompe Farmaceutici SpA, Genzyme Corp, Handok Inc, Ignyta Inc and Loxo Oncology Inc, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States High Affinity Nerve Growth Factor Receptor market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe High Affinity Nerve Growth Factor Receptor landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global High Affinity Nerve Growth Factor Receptor market. The analysts authoring the report have closely studied key strategies adopted by top players of the global High Affinity Nerve Growth Factor Receptor market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global High Affinity Nerve Growth Factor Receptor market. Readers of the report can become informed about current and future trends of the global High Affinity Nerve Growth Factor Receptor market and how they will impact market growth during the forecast period.



By Company


Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc
Segment by Type
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others

Segment by Application


Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of High Affinity Nerve Growth Factor Receptor in global and regional level.
Chapter 3Detailed analysis of High Affinity Nerve Growth Factor Receptor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, High Affinity Nerve Growth Factor Receptor revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 ASP-7962
1.2.3 AZD-7451
1.2.4 BNN-27
1.2.5 Cenegermin
1.2.6 CRB-0089
1.2.7 Others
1.3 Market by Application
1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Bile Duct Cancer
1.3.3 Papillary Thyroid Cancer
1.3.4 Low Back Pain
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
2.2 High Affinity Nerve Growth Factor Receptor Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2023)
2.4 Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 High Affinity Nerve Growth Factor Receptor Countries Ranking by Market Size
3 High Affinity Nerve Growth Factor Receptor Competitive by Company
3.1 Global High Affinity Nerve Growth Factor Receptor Revenue by Players
3.1.1 Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2018-2023)
3.1.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Players (2018-2023)
3.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by High Affinity Nerve Growth Factor Receptor Revenue
3.4 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio
3.4.1 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2024
3.5 Global Key Players of High Affinity Nerve Growth Factor Receptor Head office and Area Served
3.6 Global Key Players of High Affinity Nerve Growth Factor Receptor, Product and Application
3.7 Global Key Players of High Affinity Nerve Growth Factor Receptor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
4.1 Global High Affinity Nerve Growth Factor Receptor Historic Revenue by Type (2018-2023)
4.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Revenue by Type (2024-2034)
5 Global High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
5.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2018-2023)
5.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023)
6.2 North America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2034)
6.3 North America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2034)
6.4 North America High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023)
7.2 Europe High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2034)
7.3 Europe High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2034)
7.4 Europe High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023)
8.2 Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2034)
8.3 Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2034)
8.4 Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023)
9.2 Latin America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2034)
9.3 Latin America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2034)
9.4 Latin America High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023)
10.2 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2034)
10.3 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2034)
10.4 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Company Details
11.1.2 Array BioPharma Inc Business Overview
11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.1.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.1.5 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.1.6 Array BioPharma Inc Recent Development
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Details
11.2.2 Astellas Pharma Inc Business Overview
11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.2.4 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.2.5 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.2.6 Astellas Pharma Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Details
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Products and Services
11.3.4 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.3.5 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.3.6 AstraZeneca Plc Recent Development
11.4 Daiichi Sankyo Co Ltd
11.4.1 Daiichi Sankyo Co Ltd Company Details
11.4.2 Daiichi Sankyo Co Ltd Business Overview
11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Products and Services
11.4.4 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.4.5 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.4.6 Daiichi Sankyo Co Ltd Recent Development
11.5 Dompe Farmaceutici SpA
11.5.1 Dompe Farmaceutici SpA Company Details
11.5.2 Dompe Farmaceutici SpA Business Overview
11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Products and Services
11.5.4 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.5.5 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.5.6 Dompe Farmaceutici SpA Recent Development
11.6 Genzyme Corp
11.6.1 Genzyme Corp Company Details
11.6.2 Genzyme Corp Business Overview
11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Products and Services
11.6.4 Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.6.5 Genzyme Corp High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.6.6 Genzyme Corp Recent Development
11.7 Handok Inc
11.7.1 Handok Inc Company Details
11.7.2 Handok Inc Business Overview
11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.7.4 Handok Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.7.5 Handok Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.7.6 Handok Inc Recent Development
11.8 Ignyta Inc
11.8.1 Ignyta Inc Company Details
11.8.2 Ignyta Inc Business Overview
11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.8.4 Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.8.5 Ignyta Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.8.6 Ignyta Inc Recent Development
11.9 Loxo Oncology Inc
11.9.1 Loxo Oncology Inc Company Details
11.9.2 Loxo Oncology Inc Business Overview
11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.9.4 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.9.5 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.9.6 Loxo Oncology Inc Recent Development
11.10 Merck & Co Inc
11.10.1 Merck & Co Inc Company Details
11.10.2 Merck & Co Inc Business Overview
11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.10.4 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.10.5 Merck & Co Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
11.10.6 Merck & Co Inc Recent Development
11.11 Nerviano Medical Sciences Srl
11.11.1 Nerviano Medical Sciences Srl Company Details
11.11.2 Nerviano Medical Sciences Srl Business Overview
11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Products and Services
11.11.4 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.11.5 Nerviano Medical Sciences Srl Recent Development
11.12 Plexxikon Inc
11.12.1 Plexxikon Inc Company Details
11.12.2 Plexxikon Inc Business Overview
11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.12.4 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.12.5 Plexxikon Inc Recent Development
11.13 Proximagen Ltd
11.13.1 Proximagen Ltd Company Details
11.13.2 Proximagen Ltd Business Overview
11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Products and Services
11.13.4 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.13.5 Proximagen Ltd Recent Development
11.14 Rottapharm Biotech Srl
11.14.1 Rottapharm Biotech Srl Company Details
11.14.2 Rottapharm Biotech Srl Business Overview
11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Products and Services
11.14.4 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.14.5 Rottapharm Biotech Srl Recent Development
11.15 Sienna Biopharmaceuticals Inc
11.15.1 Sienna Biopharmaceuticals Inc Company Details
11.15.2 Sienna Biopharmaceuticals Inc Business Overview
11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Products and Services
11.15.4 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.15.5 Sienna Biopharmaceuticals Inc Recent Development
11.16 Tiziana Life Sciences Plc
11.16.1 Tiziana Life Sciences Plc Company Details
11.16.2 Tiziana Life Sciences Plc Business Overview
11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Products and Services
11.16.4 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.16.5 Tiziana Life Sciences Plc Recent Development
12 High Affinity Nerve Growth Factor Receptor Market Dynamics
12.1 High Affinity Nerve Growth Factor Receptor Industry Trends
12.2 High Affinity Nerve Growth Factor Receptor Market Drivers
12.3 High Affinity Nerve Growth Factor Receptor Market Challenges
12.4 High Affinity Nerve Growth Factor Receptor Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of ASP-7962
Table 3. Key Players of AZD-7451
Table 4. Key Players of BNN-27
Table 5. Key Players of Cenegermin
Table 6. Key Players of CRB-0089
Table 7. Key Players of Others
Table 8. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 10. Global High Affinity Nerve Growth Factor Receptor Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 12. Global High Affinity Nerve Growth Factor Receptor Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 13. Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2018-2023) & (US$ Million)
Table 14. Global High Affinity Nerve Growth Factor Receptor Market Share by Players (2018-2023)
Table 15. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2024)
Table 16. Ranking of Global Top High Affinity Nerve Growth Factor Receptor Companies by Revenue (US$ Million) in 2024
Table 17. Global 5 Largest Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue (CR5 and HHI) & (2018-2023)
Table 18. Global Key Players of High Affinity Nerve Growth Factor Receptor, Headquarters and Area Served
Table 19. Global Key Players of High Affinity Nerve Growth Factor Receptor, Product and Application
Table 20. Global Key Players of High Affinity Nerve Growth Factor Receptor, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2023)
Table 24. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 25. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2024-2034)
Table 26. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2023)
Table 28. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 29. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2024-2034)
Table 30. North America High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023) & (US$ Million)
Table 31. North America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 32. North America High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 33. North America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 34. North America High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 35. North America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 37. North America High Affinity Nerve Growth Factor Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 38. Europe High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023) & (US$ Million)
Table 39. Europe High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 40. Europe High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 41. Europe High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 42. Europe High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 43. Europe High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Europe High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 45. Europe High Affinity Nerve Growth Factor Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 46. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023) & (US$ Million)
Table 47. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 48. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 49. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 50. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 51. Asia-Pacific High Affinity Nerve Growth Factor Receptor Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 52. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Region (2018-2023) & (US$ Million)
Table 53. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue by Region (2024-2034) & (US$ Million)
Table 54. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023) & (US$ Million)
Table 55. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 56. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 57. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 58. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 59. Latin America High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 60. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 61. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 62. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Company (2021-2023) & (US$ Million)
Table 63. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2023) & (US$ Million)
Table 64. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 65. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 67. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 68. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Country (2018-2023) & (US$ Million)
Table 69. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Country (2024-2034) & (US$ Million)
Table 70. Array BioPharma Inc Company Details
Table 71. Array BioPharma Inc Business Overview
Table 72. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 73. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 74. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 75. Array BioPharma Inc Recent Development
Table 76. Astellas Pharma Inc Company Details
Table 77. Astellas Pharma Inc Business Overview
Table 78. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 79. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 80. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 81. Astellas Pharma Inc Recent Development
Table 82. AstraZeneca Plc Company Details
Table 83. AstraZeneca Plc Business Overview
Table 84. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product and Services
Table 85. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 86. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 87. AstraZeneca Plc Recent Development
Table 88. Daiichi Sankyo Co Ltd Company Details
Table 89. Daiichi Sankyo Co Ltd Business Overview
Table 90. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product and Services
Table 91. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 92. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 93. Daiichi Sankyo Co Ltd Recent Development
Table 94. Dompe Farmaceutici SpA Company Details
Table 95. Dompe Farmaceutici SpA Business Overview
Table 96. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product and Services
Table 97. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 98. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 99. Dompe Farmaceutici SpA Recent Development
Table 100. Genzyme Corp Company Details
Table 101. Genzyme Corp Business Overview
Table 102. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product and Services
Table 103. Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 104. Genzyme Corp High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 105. Genzyme Corp Recent Development
Table 106. Handok Inc Company Details
Table 107. Handok Inc Business Overview
Table 108. Handok Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 109. Handok Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 110. Handok Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 111. Handok Inc Recent Development
Table 112. Ignyta Inc Company Details
Table 113. Ignyta Inc Business Overview
Table 114. Ignyta Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 115. Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 116. Ignyta Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 117. Ignyta Inc Recent Development
Table 118. Loxo Oncology Inc Company Details
Table 119. Loxo Oncology Inc Business Overview
Table 120. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 121. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 122. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 123. Loxo Oncology Inc Recent Development
Table 124. Merck & Co Inc Company Details
Table 125. Merck & Co Inc Business Overview
Table 126. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 127. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 128. Merck & Co Inc High Affinity Nerve Growth Factor Receptor SWOT Analysis
Table 129. Merck & Co Inc Recent Development
Table 130. Nerviano Medical Sciences Srl Company Details
Table 131. Nerviano Medical Sciences Srl Business Overview
Table 132. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product and Services
Table 133. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 134. Nerviano Medical Sciences Srl Recent Development
Table 135. Plexxikon Inc Company Details
Table 136. Plexxikon Inc Business Overview
Table 137. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 138. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 139. Plexxikon Inc Recent Development
Table 140. Proximagen Ltd Company Details
Table 141. Proximagen Ltd Business Overview
Table 142. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product and Services
Table 143. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 144. Proximagen Ltd Recent Development
Table 145. Rottapharm Biotech Srl Company Details
Table 146. Rottapharm Biotech Srl Business Overview
Table 147. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product and Services
Table 148. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 149. Rottapharm Biotech Srl Recent Development
Table 150. Sienna Biopharmaceuticals Inc Company Details
Table 151. Sienna Biopharmaceuticals Inc Business Overview
Table 152. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product and Services
Table 153. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 154. Sienna Biopharmaceuticals Inc Recent Development
Table 155. Tiziana Life Sciences Plc Company Details
Table 156. Tiziana Life Sciences Plc Business Overview
Table 157. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product and Services
Table 158. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023) & (US$ Million)
Table 159. Tiziana Life Sciences Plc Recent Development
Table 160. High Affinity Nerve Growth Factor Receptor Market Trends
Table 161. High Affinity Nerve Growth Factor Receptor Market Drivers
Table 162. High Affinity Nerve Growth Factor Receptor Market Challenges
Table 163. High Affinity Nerve Growth Factor Receptor Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. High Affinity Nerve Growth Factor Receptor Product Picture
Figure 2. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global High Affinity Nerve Growth Factor Receptor Market Share by Type: 2024 VS 2034
Figure 4. ASP-7962 Features
Figure 5. AZD-7451 Features
Figure 6. BNN-27 Features
Figure 7. Cenegermin Features
Figure 8. CRB-0089 Features
Figure 9. Others Features
Figure 10. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 11. Global High Affinity Nerve Growth Factor Receptor Market Share by Application: 2024 VS 2034
Figure 12. Bile Duct Cancer
Figure 13. Papillary Thyroid Cancer
Figure 14. Low Back Pain
Figure 15. Lung Cancer
Figure 16. Others
Figure 17. High Affinity Nerve Growth Factor Receptor Report Years Considered
Figure 18. Global High Affinity Nerve Growth Factor Receptor Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global High Affinity Nerve Growth Factor Receptor Market Size 2018-2034 (US$ Million)
Figure 20. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region: 2024 VS 2034
Figure 21. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Region in 2018 VS 2024
Figure 22. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share Forecast by Region (2024-2034)
Figure 23. Global Top 10 High Affinity Nerve Growth Factor Receptor Countries Ranking by Market Size (US$ Million) in 2024
Figure 24. Global High Affinity Nerve Growth Factor Receptor Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 25. Global High Affinity Nerve Growth Factor Receptor Market Share by Players in 2024
Figure 26. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2024)
Figure 27. The Top 10 and 5 Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue in 2024
Figure 28. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company in 2024
Figure 29. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 30. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 31. North America High Affinity Nerve Growth Factor Receptor Revenue Share by Country (2018-2034)
Figure 32. U.S. High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 33. Canada High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 34. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company in 2024
Figure 35. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 36. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 37. Europe High Affinity Nerve Growth Factor Receptor Revenue Share by Country (2018-2034)
Figure 38. Germany High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 39. France High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 40. U.K. High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 41. Italy High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 42. Russia High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 43. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company in 2024
Figure 44. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 45. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 46. Asia Pacific High Affinity Nerve Growth Factor Receptor Revenue Share by Region (2018-2034)
Figure 47. China High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 48. Japan High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 49. South Korea High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 50. India High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 51. Australia High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 52. Taiwan High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 53. Indonesia High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 54. Thailand High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 55. Malaysia High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 56. Philippines High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 57. Vietnam High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 58. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company in 2024
Figure 59. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 60. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 61. Latin America High Affinity Nerve Growth Factor Receptor Revenue Share by Country (2018-2034)
Figure 62. Mexico High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 63. Brazil High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 64. Argentina High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 65. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company in 2024
Figure 66. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 67. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 68. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Share by Country (2018-2034)
Figure 69. Turkey High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 70. Saudi Arabia High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 71. UAE High Affinity Nerve Growth Factor Receptor Revenue (2018-2034) & (US$ Million)
Figure 72. Array BioPharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 73. Astellas Pharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 74. AstraZeneca Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 75. Daiichi Sankyo Co Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 76. Dompe Farmaceutici SpA Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 77. Genzyme Corp Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 78. Handok Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 79. Ignyta Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 80. Loxo Oncology Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 81. Merck & Co Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 82. Nerviano Medical Sciences Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 83. Plexxikon Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 84. Proximagen Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 85. Rottapharm Biotech Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 86. Sienna Biopharmaceuticals Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 87. Tiziana Life Sciences Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries